Pediatricians basically take a “vow of poverty,” but that’s just one reason for the shortage of children’s physicians. https://trib.al/V1MTdXM
关于我们
Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: https://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews
- 网站
-
https://www.statnews.com
STAT的外部链接
- 所属行业
- 网络新闻
- 规模
- 51-200 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 领域
- news、science news、medicine、health、biotech、pharma、health tech、covid、hospitals和business
地点
-
主要
获取路线
1 Exchange Pl
US，Massachusetts，Boston，02109
STAT员工
动态
-
Departures of key staff from the FDA could lead to delays in inspections and product approvals. https://trib.al/Jv3LAov
-
“It seems the Trump administration is arguing that people like me are neither male nor female but simply ‘disordered,’” writes Kimberly Zieselman. https://trib.al/P5PbM9R
-
As U.S. punts on ultra-processed food, California seeks to ban "particularly harmful" ones from school lunches. https://trib.al/Eo9iiKV
-
AHRQ, a small government agency responsible for health care quality research, is feared to be the latest target for mass layoffs by the Trump administration. https://trib.al/s4nW3Na
-
Gene therapy pioneer Jim Wilson and researcher Kiran Musunuru are using contrasting approaches to overcome “irrational pessimism” clouding the field. #STATBreakthrough https://trib.al/WquLXdS
-
Trump's former FDA commissioner criticized the current administration's approach to measles and infant formula at #STATBreakthrough https://trib.al/3P7IRCv
-
Zynex Medical disclosed that an insurer, a major client, was suspending payments and reviewing prior claims. https://trib.al/EleVyyK
-
The FDA cleared Alnylam’s therapy for the heart disease ATTR-CM, setting the company up to compete with drugs from BridgeBio and Pfizer. https://trib.al/vkXRrhD